Mirum Pharmaceuticals, Inc. (MIRM)
88.51
-2.21
(-2.44%)
USD |
NASDAQ |
Mar 20, 16:00
88.54
+0.04
(+0.04%)
After-Hours: 20:00
Mirum Pharmaceuticals Research and Development Expense (Quarterly) : 51.03M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | 192.41M |
| Insmed, Inc. | 254.91M |
| Ionis Pharmaceuticals, Inc. | 279.36M |
| BridgeBio Pharma, Inc. | 116.42M |
| XOMA Royalty Corp. | 0.281M |